Expertise in
6
conditions

Barbara Hero

Kerpener Str. 62, 
Koeln, NW, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
6
conditions
Kerpener Str. 62, 
Koeln, NW, DE 

Overview

Barbara Hero practices practicing medicine in Koeln, Germany.

Ms. Hero is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Opsoclonus-Myoclonus Syndrome, Ganglioneuroma, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 104 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Kerpener Str. 62, Koeln, NW 50924, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Post-Authorisation Safety Study Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta
A Post-Authorisation Safety Study Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta
Enrollment Status: Recruiting
Publish Date: February 07, 2024
Intervention Type: Other
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
Enrollment Status: Active_not_recruiting
Publish Date: April 30, 2026
Intervention Type: Drug
Study Drugs: Rituximab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide, Methotrexate, Prednisolone, Vincristine
Study Phase: Phase 3
View 1 Less Clinical Trial

104 Total Publications

Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.
Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.
Journal: JCO precision oncology
Published: July 16, 2026

Frequently Asked Questions about Barbara Hero

Is Barbara Hero a top-rated expert for Neuroblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Barbara Hero is classified as an Distinguished expert for Neuroblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Barbara Hero participate in research or clinical trials?

Yes. Barbara Hero has published 104 articles and abstracts on conditions like Neuroblastoma. You can view a list of Barbara Hero's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hero's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile